1. Home
  2. VALN vs ASLE Comparison

VALN vs ASLE Comparison

Compare VALN & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • ASLE
  • Stock Information
  • Founded
  • VALN 2012
  • ASLE 2008
  • Country
  • VALN France
  • ASLE United States
  • Employees
  • VALN N/A
  • ASLE N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • ASLE Industrial Specialties
  • Sector
  • VALN Health Care
  • ASLE Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • ASLE Nasdaq
  • Market Cap
  • VALN 332.0M
  • ASLE 334.7M
  • IPO Year
  • VALN 2021
  • ASLE N/A
  • Fundamental
  • Price
  • VALN $3.76
  • ASLE $6.16
  • Analyst Decision
  • VALN Strong Buy
  • ASLE Strong Buy
  • Analyst Count
  • VALN 2
  • ASLE 3
  • Target Price
  • VALN $18.50
  • ASLE $9.00
  • AVG Volume (30 Days)
  • VALN 30.5K
  • ASLE 292.3K
  • Earning Date
  • VALN 11-07-2024
  • ASLE 11-07-2024
  • Dividend Yield
  • VALN N/A
  • ASLE N/A
  • EPS Growth
  • VALN N/A
  • ASLE N/A
  • EPS
  • VALN N/A
  • ASLE N/A
  • Revenue
  • VALN $176,817,979.00
  • ASLE $344,747,000.00
  • Revenue This Year
  • VALN $24.30
  • ASLE $6.62
  • Revenue Next Year
  • VALN $16.05
  • ASLE $17.49
  • P/E Ratio
  • VALN N/A
  • ASLE N/A
  • Revenue Growth
  • VALN N/A
  • ASLE 2.84
  • 52 Week Low
  • VALN $3.65
  • ASLE $4.53
  • 52 Week High
  • VALN $10.76
  • ASLE $13.43
  • Technical
  • Relative Strength Index (RSI)
  • VALN 37.11
  • ASLE 54.00
  • Support Level
  • VALN $3.62
  • ASLE $6.09
  • Resistance Level
  • VALN $4.09
  • ASLE $6.28
  • Average True Range (ATR)
  • VALN 0.20
  • ASLE 0.22
  • MACD
  • VALN 0.03
  • ASLE -0.04
  • Stochastic Oscillator
  • VALN 39.44
  • ASLE 39.29

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About ASLE AerSale Corporation

AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.

Share on Social Networks: